Clincosm LogoSign in Get a demo

hypersensitivity

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Reaction, Hypersensitivity, Perioperative Complication Trial in Edegem (Full dose DPT with propofol, Full dose DPT with

Not yet recruiting
  • Allergic Reaction
  • +6 more
  • Full dose DPT with propofol
  • +11 more
  • Edegem, Antwerp, Belgium
    Antwerp University Hospital
Sep 26, 2023

Hypersensitivity, Hay Fever, Rhinitis, Allergic, Seasonal Trial (Polvac Grass+Rye)

Not yet recruiting
  • Hypersensitivity
  • +3 more
  • Polvac Grass+Rye
  • (no location specified)
Jul 17, 2023

Eczema, Atopic, Inflammation; Skin, Eczema Trial in Singapore (Nutrients-fortified egg, Regular egg)

Active, not recruiting
  • Eczema, Atopic
  • +3 more
  • Nutrients-fortified egg
  • Regular egg
  • Singapore, Singapore
    National University of Singapore
Jun 13, 2023

Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous

Completed
  • Common Cold
  • +2 more
    • Berlin, Germany
      Schlesinger Group
    Jan 31, 2023

    Activation and Function of Eosinophils in Conditions With Blood

    Recruiting
    • Immune System Diseases
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 18, 2023

      Characterizing the Inflammation Around Dental Implants

      Enrolling by invitation
      • Peri-Implantitis
      • +6 more
      • Clinical examination of a dental implant
      • +2 more
      • Montréal, Quebec, Canada
        Montreal General Hospital - Oral & Maxillofacial Surgery Clinic
      Dec 22, 2022

      Hypersensitivity Trial in Winston-Salem (KeraStat® Cream, KeraStat Gel, Biafine)

      Completed
      Has Results
      • Hypersensitivity
      • KeraStat® Cream
      • +4 more
      • Winston-Salem, North Carolina
        PMG Research, Inc.
      Oct 19, 2022

      Chronic Pain, Adults 21 and Older, Multiple Chronic Overlapping Pain Conditions Trial in Chestnut Hill (High Intensity Quell,

      Not yet recruiting
      • Chronic Pain
      • +3 more
      • High Intensity Quell
      • Low Intensity Quell
      • Chestnut Hill, Massachusetts
        Brigham and Women's Hospital Pain Management Center
      Sep 12, 2022

      Quaternary Ammonium, Hypersensitivity Trial in Paris (serum punction, skin swab in elbow folds)

      Not yet recruiting
      • Quaternary Ammonium
      • Hypersensitivity
      • serum punction
      • skin swab in elbow folds
      • Paris, France
        Bichat Hospital
      Jul 28, 2022

      Hypersensitivity Trial in Quebec (tree 12 SQ-Bet, GRASS 2800 BAU, RAGWEED 12 AMB A 1-U)

      Completed
      • Hypersensitivity
      • tree 12 SQ-Bet
      • +3 more
      • Quebec, Canada
        Clinique specialisee en allergie de la capitale
      May 31, 2022

      Asthma, Bronchial Diseases, Respiratory Tract Diseases Trial in Worldwide (Tezepelumab, Placebo)

      Completed
      Has Results
      • Asthma
      • +8 more
      • Tezepelumab
      • Placebo
      • Denver, Colorado
      • +27 more
      Feb 18, 2022

      Hypersensitivity Trial (desloratadine, levocetirizine, Desloratadine tablet)

      Completed
      Has Results
      • Hypersensitivity
      • (no location specified)
      Feb 7, 2022

      Hypersensitivity Trial in Giza (Fluoride varnish with xylitol coated calcium and phosphate)

      Completed
      • Hypersensitivity
      • Fluoride varnish with xylitol coated calcium and phosphate
      • Giza, Egypt
        Cairo U
      Jan 20, 2022

      Hypersensitivity Trial in Gainesville (Mometasone furoate drug formulation (MFF) 1, Mometasone furoate drug formulation (MFF) 2)

      Completed
      • Hypersensitivity
      • Mometasone furoate drug formulation (MFF) 1
      • Mometasone furoate drug formulation (MFF) 2
      • Gainesville, Florida
        Department of Pharmaceutics, University of Florida
      Nov 15, 2021

      Dermatitis, Atopic, Dermatitis, Eczema Trial in Hamilton (Benralizumab, Placebo Control)

      Completed
      • Dermatitis, Atopic
      • +9 more
      • Hamilton, Ontario, Canada
        McMaster Cardio-Respiratory Research Lab
      Oct 14, 2021

      Asthma, Occupational, Hypersensitivity Trial in Tromsø (Nozzles (NZ), Cleaning of surfaces (CS))

      Enrolling by invitation
      • Asthma, Occupational
      • Hypersensitivity
      • Nozzles (NZ)
      • Cleaning of surfaces (CS)
      • Tromsø, Norway
        University Hospital of Nothern Norway
      Oct 4, 2021

      Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Placebo)

      Completed
      Has Results
      • Dermatitis
      • +9 more
      • PF-04965842 100 mg
      • +2 more
      • Birmingham, Alabama
      • +234 more
      Sep 17, 2021

      Hypersensitivity, Food Allergy, Hypersensitivity, Food Trial in Los Angeles, Mountain View, San Diego (Omalizumab, Dupilumab,

      Recruiting
      • Hypersensitivity
      • +4 more
      • Los Angeles, California
      • +2 more
      Aug 25, 2021

      Central Sensitisation, Hypersensitivity Trial in Sinop

      Recruiting
      • Central Sensitisation
      • Hypersensitivity
        • Sinop, Boyabat, Turkey
          Feyza Nur YUCEL
        Aug 15, 2021

        Asthma, Bronchial Diseases, Respiratory Tract Diseases Trial in Louisville (Propeller Health intervention)

        Completed
        Has Results
        • Asthma
        • +8 more
        • Propeller Health intervention
        • Louisville, Kentucky
          Jefferson County
        Jul 16, 2021

        Learn More About Safety of Ultravist in Children and in Elderly

        Completed
        • Hypersensitivity
        • Iopromide(Ultravist, BAY86-4877)
        • Berlin, Germany
          Four company sponsored non-interventional studies with iopromide
        Jul 19, 2021

        Hypersensitivity Reactions to Propofol in Children

        Completed
        • Hypersensitivity
        • +2 more
        • Jette, Brussel, Belgium
          UZ Brussel
        Apr 6, 2021

        Allergic Rhinitis, Inflammation, Respiratory Tract Diseases Trial in Guangzhou (Budesonide nasal spray, Placebo)

        Completed
        • Allergic Rhinitis
        • +3 more
        • Budesonide nasal spray
        • Placebo
        • Guangzhou, Guangdong, China
          Guangzhou institute of respiratory disease
        Mar 6, 2021

        Airway Inflammation and Bronchial Hyperresponsiveness in

        Completed
        • Rhinitis
        • +3 more
          • Guangzhou, Guangdong, China
            Guangzhou institute of respiratory disease
          Mar 6, 2021

          Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Dupilumab)

          Completed
          Has Results
          • Dermatitis
          • +9 more
          • PF-04965842 100 mg
          • +4 more
          • Birmingham, Alabama
          • +215 more
          Dec 21, 2020